Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE)

349 filings reported holding RARE - Ultragenyx Pharmaceutical Inc. - COMMON STOCK as of Q3 2024.
Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) has 299 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 86,896,233 shares of 95,963,102 outstanding shares and own 91% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (9,945,473 shares), BlackRock, Inc. (5,828,848 shares), SANDS CAPITAL MANAGEMENT, LLC (5,118,255 shares), WELLINGTON MANAGEMENT GROUP LLP (4,165,424 shares), PRICE T ROWE ASSOCIATES INC /MD/ (3,068,654 shares), ALKEON CAPITAL MANAGEMENT LLC (3,011,716 shares), STATE STREET CORP (2,664,077 shares), Clearbridge Investments, LLC (2,426,977 shares), FEDERATED HERMES, INC. (2,110,700 shares), and Rock Springs Capital Management LP (1,978,272 shares).
This table shows the top 299 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.